DIAsource ImmunoAssays
About DIAsource ImmunoAssays
DIAsource ImmunoAssays is a company founded in 1996 was acquired by BioVendor in July 2017.. The company has 73 employees as of December 31, 2022.
- Employees 73 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Diasource Immunoassays S.A.
-
Annual Revenue
$18.79 M (USD)8as on Dec 31, 2022
-
Net Profit
$-61.45 K (USD)-107as on Dec 31, 2022
-
EBITDA
$1.8 M (USD)-30as on Dec 31, 2022
-
Latest Funding Round
-
Investors
Anteo Tech
& 1 more
-
Employee Count
73
as on Dec 31, 2022
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of DIAsource ImmunoAssays
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DIAsource ImmunoAssays
DIAsource ImmunoAssays has secured backing from 2 investors. Prominent investors backing the company include Anteo Tech and BioVendor. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Coupling reagents are developed for biomolecules immobilization on surfaces.
|
Founded Year | Domain | Location | |
|
Diagnostic products and ingredients are developed, manufactured, and marketed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DIAsource ImmunoAssays
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DIAsource ImmunoAssays
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diasource Immunoassays Comparisons
Competitors of DIAsource ImmunoAssays
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about DIAsource ImmunoAssays
When was DIAsource ImmunoAssays founded?
DIAsource ImmunoAssays was founded in 1996.
How many employees does DIAsource ImmunoAssays have?
As of Dec 31, 2022, the latest employee count at DIAsource ImmunoAssays is 73.
What is the annual revenue of DIAsource ImmunoAssays?
Annual revenue of DIAsource ImmunoAssays is $18.79M as on Dec 31, 2022.
What does DIAsource ImmunoAssays do?
DIAsource ImmunoAssays, formerly known as BioSource develops, manufactures and markets diagnostic products in the field of infectious diseases and endocrinology. The company offers a wide range of RIA and ELISA tests in the field of Auto-immunity, Biogenic amines, Bone metabolism, Oncology, Cardiovascular Salt balance, Diabetes Metabolism, Drug of Abuse, Fertility, Gastrointestinal metabolism, Growth factors,Immunology markers, Infectious diseases, and Thyroid function. It also offers reagents for open ELISA automated analyzers as well as antibodies for use in in-vitro diagnostic assays. The companys Vitamin D assay allows detection and measurement of various forms of Vitamin D metabolites : 25OH Vitamin D, 1,25(OH)2 Vitamin D. On January 11, 2016, the company has been acquired by Anteo.
Who are DIAsource ImmunoAssays's investors?
DIAsource ImmunoAssays has 2 investors. Key investors include Anteo Tech, and BioVendor.